Advertisement
Screener

INNOVATION PHARMACEUTICALS INC. Patents: Applications Rejected

INNOVATION PHARMACEUTICALS INC. Patent Applications Rejected

9 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-09-22: Application 18472450; Invention Arylamide Compounds For Treatment And Prevention Of Fungal Infections; Applicant Innovation Pharmaceuticals Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
  • 2023-05-08: Application 18313991; Invention HOST DEFENSE PROTEIN (HDP) MIMETICS FOR PROPHYLAXIS AND/; Applicant INNOVATION PHARMACEUTICALS INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2020-10-28: Application 17082666; Invention Arylamide compounds and compositions and uses thereof; Applicant Innovation Pharmaceuticals Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2018-11-13: Application 16188904; Invention Arylamide compounds and compositions and uses thereof; Applicant Innovation Pharmaceuticals Inc.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2023-09-2218472450Arylamide Compounds For Treatment And Prevention Of Fungal InfectionsInnovation Pharmaceuticals Inc.Abandoned -- Incomplete Application (Pre-examination)US20240139188A1
Gustavo H. Goldman
Thaila Fernanda dos Reis
Brazil
Brazil
2023-05-0818313991HOST DEFENSE PROTEIN (HDP) MIMETICS FOR PROPHYLAXIS AND/OR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACTINNOVATION PHARMACEUTICALS INC.Abandoned -- Failure to Respond to an Office ActionUS20230310435A1
Krishna MENON
United States
BAEK, BONG-SOOK
2020-10-2817082666Arylamide compounds and compositions and uses thereofInnovation Pharmaceuticals Inc.Abandoned -- Failure to Respond to an Office ActionUS20210093636A1
Richard W. Scott
United States
MCMILLIAN, KARA RENITA
2018-11-1316188904Arylamide compounds and compositions and uses thereofInnovation Pharmaceuticals Inc.Abandoned -- Failure to Respond to an Office ActionUS20190314370A1
Richard W. Scott
United States
MCMILLIAN, KARA RENITA
2017-05-1715597872Methods Of Preparing Carbocyclic NucleosidesInnovation Pharmaceuticals Inc.Abandoned -- Failure to Respond to an Office ActionUS20170334913A1
Siya Ram
Krishna Menon
United States
United States
DANIEL, LAURA M
2016-02-1215042923Host Defense Protein (HDP) Mimetics For Prophylaxis And/Or Treatment Of Inflammatory Diseases Of The Gastrointestinal TractCELLCEUTIX CORPORATIONAbandoned -- Failure to Respond to an Office ActionUS20160243117A1
Krishna MENON
United States
BAEK, BONG-SOOK
2014-12-1914576783Processes For Preparing A Polymeric CompoundCellceutix CorporationAbandoned -- Failure to Pay Issue FeeUS20150197485A1
Robert W. Kavash
Haizhong Tang
Carol Mulrooney
Dahui Liu
United States
United States
United States
United States
KUMAR, SHAILENDRA
2014-08-0514452116ANTI-MALARIAL COMPOUNDSCellceutix CorporationAbandoned -- Failure to Respond to an Office ActionUS20150072997A1
Richard W. Scott
Doron Greenbaum
Dahui Liu
Xiaodong Fan
Yongjiang Xu
Haizhong Tang
Ehab Khalil
United States
United States
United States
United States
United States
United States
United States
RAO, DEEPAK R
2013-12-0914100785Polymeric Compounds And Methods Of Making And Using The SameCellceutix CorporationAbandoned -- Failure to Respond to an Office ActionUS20140308317A1
Xiaodong Fan
Yongjiang Xu
Dahui Liu
Michael J. Costanzo
Richard W. Scott
United States
United States
United States
United States
United States
NEAGU, IRINA